| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 11/22/2023 | -22.91% | Goldman Sachs | $36 → $40 | Maintains | Neutral |
| 11/21/2023 | 15.64% | Cantor Fitzgerald | → $60 | Reiterates | Overweight → Overweight |
| 11/21/2023 | -22.91% | Goldman Sachs | $36 → $40 | Maintains | Neutral |
| 11/21/2023 | 11.79% | Needham | → $58 | Reiterates | Buy → Buy |
| 11/21/2023 | 21.42% | Keybanc | $50 → $63 | Maintains | Overweight |
| 10/03/2023 | -30.62% | Goldman Sachs | $41 → $36 | Maintains | Neutral |
| 10/03/2023 | -3.63% | Keybanc | → $50 | Initiates Coverage On | → Overweight |
| 09/05/2023 | -20.98% | Goldman Sachs | $53 → $41 | Maintains | Neutral |
| 08/07/2023 | 6% | TD Cowen | $33 → $55 | Maintains | Outperform |
| 08/02/2023 | 2.15% | Goldman Sachs | $32 → $53 | Maintains | Neutral |
| 08/02/2023 | 34.91% | Citigroup | $52 → $70 | Maintains | Buy |
| 08/01/2023 | 17.57% | Craig-Hallum | $48 → $61 | Maintains | Buy |
| 08/01/2023 | — | William Blair | Downgrades | Outperform → Market Perform | |
| 08/01/2023 | -3.63% | DA Davidson | $36 → $50 | Downgrades | Buy → Neutral |
| 08/01/2023 | 25.28% | Raymond James | $35 → $65 | Maintains | Outperform |
| 07/31/2023 | 11.79% | Needham | $43 → $58 | Maintains | Buy |
| 07/25/2023 | -7.49% | Craig-Hallum | $35 → $48 | Maintains | Buy |
| 07/25/2023 | -13.27% | Northland Capital Markets | $35 → $45 | Maintains | Outperform |
| 07/25/2023 | -17.12% | Needham | $36 → $43 | Maintains | Buy |
| 07/11/2023 | 0.22% | Citigroup | $32 → $52 | Maintains | Buy |
| 06/29/2023 | -22.91% | UBS | $34 → $40 | Downgrades | Buy → Neutral |
| 05/24/2023 | -30.62% | DA Davidson | $30 → $36 | Maintains | Buy |
| 05/24/2023 | -42.18% | Goldman Sachs | $16 → $30 | Maintains | Neutral |
| 05/24/2023 | -30.62% | Needham | $31 → $36 | Maintains | Buy |
| 05/22/2023 | -30.62% | Deutsche Bank | $31 → $36 | Maintains | Buy |
| 05/22/2023 | — | William Blair | Reinstates | → Outperform | |
| 05/22/2023 | -32.54% | Northland Capital Markets | $30 → $35 | Maintains | Outperform |
| 05/22/2023 | -38.33% | Baird | $28 → $32 | Maintains | Outperform |
| 05/03/2023 | -36.4% | TD Cowen | $20 → $33 | Maintains | Outperform |
| 05/03/2023 | -42.18% | DA Davidson | $22 → $30 | Maintains | Buy |
| 05/03/2023 | -46.03% | Baird | $24 → $28 | Maintains | Outperform |
| 05/02/2023 | -40.25% | Deutsche Bank | $22 → $31 | Maintains | Buy |
| 05/02/2023 | -42.18% | Northland Capital Markets | $20 → $30 | Maintains | Outperform |
| 05/02/2023 | -40.25% | Needham | $25 → $31 | Maintains | Buy |
| 05/02/2023 | -32.54% | Raymond James | $23 → $35 | Maintains | Outperform |
| 04/20/2023 | -32.54% | Cantor Fitzgerald | $24 → $35 | Maintains | Overweight |
| 04/17/2023 | -32.54% | Craig-Hallum | → $35 | Initiates Coverage On | → Buy |
| 04/10/2023 | -38.33% | Citigroup | $16 → $32 | Maintains | Buy |
| 03/24/2023 | -51.82% | Needham | $18 → $25 | Maintains | Buy |
| 01/31/2023 | -73.02% | Goldman Sachs | $10 → $14 | Maintains | Neutral |
| 01/31/2023 | -65.31% | Needham | $17 → $18 | Maintains | Buy |
| 11/23/2022 | -80.73% | Goldman Sachs | $13 → $10 | Maintains | Neutral |
| 11/22/2022 | -69.16% | Citigroup | $21 → $16 | Maintains | Buy |
| 11/22/2022 | -67.24% | Needham | $21 → $17 | Maintains | Buy |
| 10/11/2022 | -74.94% | Goldman Sachs | $19 → $13 | Maintains | Neutral |
| 09/19/2022 | -67.24% | UBS | → $17 | Initiates Coverage On | → Buy |
| 08/02/2022 | -57.6% | Deutsche Bank | $19 → $22 | Maintains | Buy |
| 08/02/2022 | -61.45% | Baird | $18 → $20 | Maintains | Outperform |
| 08/02/2022 | -55.67% | Raymond James | $18 → $23 | Maintains | Outperform |
| 08/02/2022 | -59.53% | Needham | $18 → $21 | Maintains | Buy |
| 07/25/2022 | -63.38% | Goldman Sachs | → $19 | Initiates Coverage On | → Neutral |
| 07/21/2022 | -53.74% | Cantor Fitzgerald | → $24 | Initiates Coverage On | → Overweight |
| 07/05/2022 | -65.31% | Raymond James | → $18 | Initiates Coverage On | → Outperform |
| 07/05/2022 | -65.31% | Needham | → $18 | Initiates Coverage On | → Buy |
| 07/01/2022 | -71.09% | Citigroup | → $15 | Initiates Coverage On | → Buy |
| 06/23/2022 | -63.38% | Deutsche Bank | → $19 | Initiates Coverage On | → Buy |
| 06/23/2022 | -65.31% | Baird | → $18 | Initiates Coverage On | → Outperform |
| 06/21/2022 | -65.31% | Cowen & Co. | → $18 | Initiates Coverage On | → Outperform |
What is the target price for Symbotic (SYM)?
The latest price target for Symbotic (NASDAQ: SYM) was reported by Goldman Sachs on November 22, 2023. The analyst firm set a price target for $40.00 expecting SYM to fall to within 12 months (a possible -22.91% downside). 42 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Symbotic (SYM)?
The latest analyst rating for Symbotic (NASDAQ: SYM) was provided by Goldman Sachs, and Symbotic maintained their neutral rating.
When is the next analyst rating going to be posted or updated for Symbotic (SYM)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Symbotic, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Symbotic was filed on November 22, 2023 so you should expect the next rating to be made available sometime around November 22, 2024.
Is the Analyst Rating Symbotic (SYM) correct?
While ratings are subjective and will change, the latest Symbotic (SYM) rating was a maintained with a price target of $36.00 to $40.00. The current price Symbotic (SYM) is trading at is $51.89, which is out of the analyst's predicted range.